What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

When is the Sai Life Sciences Limited IPO allotment date?

The basis of allotment for Sai Life Sciences Limited IPO is scheduled to be finalized on 16 Dec 2024.

Where can I check Sai Life Sciences Limited IPO allotment status?

You can check your allotment status on the official registrar portal (Kfin Technologies Limited) or on the BSE India website using your PAN card number or application number.

When will unallotted IPO application funds be unblocked?

Refund initiation and UPI mandate revocation for unallotted applications starts on or around 17 Dec 2024.

Sai Life Sciences Limited

ListedMainboard

Pharmaceuticals & Healthcare · NSE / BSE

Sai Life Sciences Limited, incorporated in January 1999, specializes in researching, developing, and manufacturing small-molecule new chemical entities, serving over 280 innovator pharmaceutical companies in FY 2024, including more than 230 clients as of September 2024. Collaborating with 18 of the top 25 global pharmaceutical firms, the company provides services across the US, UK, Europe, and Japan, offering CMC/CDMO capabilities, integrated discovery through CRO services, and support in biology, chemistry, and pharmacokinetics. Supported by a workforce of 3,135 employees, including 2,353 scientific staff with 302 Ph.D.s and 1,475 master’s degrees, Sai Life Sciences drives innovation with a globally positioned business development team of 16 professionals.

Price Band

₹522 – ₹549

Issue Size

₹3043 Cr

Lot Size

27 shares

GMP

₹71

+12.9%

Est. Listing

₹620

at current GMP

Subscribed

10.27x

overall

Open

11 Dec 2024

13 Dec 2024

Allotment

16 Dec 2024

Refund

17 Dec 2024

Demat Credit

18 Dec 2024

Listing

18 Dec 2024

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Official Registrar Verification

Sai Life Sciences Limited Allotment Status

Designated Registrar: Kfin Technologies Limited

Check Allotment Status Registrar Portal BSE Portal

Allotment Date

16 Dec 2024

Basis finalization

Refunds Initiate

17 Dec 2024

Mandate release

Demat Credit

18 Dec 2024

Shares in demat

Listing Debut

18 Dec 2024

Trading begins

How to Check Sai Life Sciences Limited IPO Allotment Status

Click the Check on Registrar button above to visit Kfin Technologies Limited's allotment portal.
Select Sai Life Sciences Limited from the dropdown company list.
Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
Enter your details accurately and solve the Captcha code.
Click Submit / Search to view the number of shares applied and allotted to you.

About Sai Life Sciences Limited Public Issue & Market Profile

Sai Life Sciences Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹3,042.62 Crores. The shares are offered at a price band of ₹522 to ₹549 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Public Issue & Allotment Procedure:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Official Allotment Timelines & Registrar Guidance:

Following the close of bidding on 2024-12-13, the basis of allotment is scheduled to be finalized on 2024-12-16. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.

Frequently Asked Questions

What if my name is not showing on the registrar portal?

Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.

How will I receive the refund if I don't get allotment?

Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.